Part:BBa_K2923021:Experience
Introduction
To validate the designed constructs we decided to test Guanine switch-on (active auto-cleavage in the presence of ligand). For negative control, we choose an inactive form of aptazyme: mutation at the ribozyme domain. iGEM Strasbourg designed construct requires the use of aptazyme linked to MS2 and PP7 stem-loops. The following results described MS2-MS2-Aptazyme-PP7-PP7 activity in in-vitro and in-vivo assays.
In-vitro assay of BBa_K2923021
In order to check MS2-MS2-Guanine-PP7-PP7 cleavage activities, in-vitro transcription products were analyzed by 2% agarose gel with urea (Figure 1).
Inactive aptazyme did not present aptazyme catalytic activity, which confirms their use as an efficient negative control.
To see in-vivo assays results of MS2-MS2-Guanine-PP7-PP7 aptazymes see BBa_K2923020.
User Reviews
UNIQ063cbc502b416358-partinfo-00000001-QINU UNIQ063cbc502b416358-partinfo-00000002-QINU